452 filings
8-K
AKTX
Akari Therapeutics Plc
5 Jun 24
Departure of Directors or Certain Officers
5:00pm
425
AKTX
Akari Therapeutics Plc
4 Jun 24
Business combination disclosure
4:30pm
8-K
AKTX
Akari Therapeutics Plc
4 Jun 24
Entry into a Material Definitive Agreement
8:02am
ARS
2023 FY
AKTX
Akari Therapeutics Plc
3 Jun 24
Annual report to shareholders
5:45pm
DEF 14A
AKTX
Akari Therapeutics Plc
Definitive proxy
3 Jun 24
4:21pm
8-K
nrdd67q 9gpgo
16 May 24
Akari Therapeutics Reports First Quarter
8:05am
8-K
ujgyno12fk9np jht1vy
7 May 24
Cost Associated with Exit or Disposal Activities
5:05pm
425
mttn51h upg9v
1 May 24
Business combination disclosure
5:27pm
8-K
gnig9z69yw0t a2rnqo
1 May 24
Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger Entity
5:04pm
8-K
g3n1yoqldfnt83
11 Apr 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6:30am
8-K
gzhgss5
1 Apr 24
Akari Therapeutics Reports Full-Year
6:30am
425
2ljw4mu4 jt4zdzssu
11 Mar 24
Business combination disclosure
5:25pm
8-K
j2d6n6o4d hjh7gft4l
11 Mar 24
Entry into a Material Definitive Agreement
5:24pm
425
i09sf0k9 h3igbkcg
5 Mar 24
Business combination disclosure
4:57pm
425
xbrozop 4oor8zjozl
5 Mar 24
Business combination disclosure
8:34am
8-K
by465qwk5v1sf 1j0h
5 Mar 24
Entry into a Material Definitive Agreement
8:28am
D
kkrhzr5qu1w6j e11qb2
9 Jan 24
$2.00 mm in equity / securities to be acquired, sold $2.00 mm, 2 investors
5:25pm
8-K
yvjr5q5q0oclpo4oirt
2 Jan 24
Akari Therapeutics Announces Existing Investors Support the Company
4:30pm